Products Categories
CAS No.: | 80830-42-8 |
---|---|
Name: | Rentiapril |
Article Data: | 4 |
Molecular Structure: | |
Formula: | C13H15 N O4 S2 |
Molecular Weight: | 313.398 |
Synonyms: | 4-Thiazolidinecarboxylicacid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R-cis)-; Fentiapril;Rentiapril; SA 446 |
Density: | 1.451g/cm3 |
Melting Point: | 147°C (rough estimate) |
Boiling Point: | 553.7°C at 760 mmHg |
Flash Point: | 288.7°C |
PSA: | 141.94000 |
LogP: | 1.67720 |
IUPAC Name: (2R,4R)-2-(2-Hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid
Synonyms of Fentiapril (CAS NO.80830-42-8) : (2R,4R)-2-(o-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid ; Prescrin ; Rentiapril ; Rentiaprilum ; 4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R-cis)-
InChI: InChI=1/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1
CAS NO:80830-42-8
Molecular Formula:C13H15NO4S2
Molecular Weight :313.3925
Molecular Structure :
Index of Refraction: 1.66
Surface Tension: 70.1 dyne/cm
Density: 1.451 g/cm3
Flash Point: 288.7 °C
Enthalpy of Vaporization: 87.82 kJ/mol
Boiling Point: 553.7 °C at 760 mmHg
Vapour Pressure: 4.29E-13 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 200mg/kg (200mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | intraperitoneal | 1gm/kg (1000mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | intravenous | 946mg/kg (946mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | oral | 8050mg/kg (8050mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | subcutaneous | 2213mg/kg (2213mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | intraperitoneal | 921mg/kg (921mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | intravenous | 884mg/kg (884mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | oral | 8290mg/kg (8290mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | subcutaneous | 1369mg/kg (1369mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |